IBDEI0VV ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14187,1,4,0)
 ;;=4^I69.942
 ;;^UTILITY(U,$J,358.3,14187,2)
 ;;=^5133582
 ;;^UTILITY(U,$J,358.3,14188,0)
 ;;=I69.944^^83^822^31
 ;;^UTILITY(U,$J,358.3,14188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14188,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Lower Nondominant Side
 ;;^UTILITY(U,$J,358.3,14188,1,4,0)
 ;;=4^I69.944
 ;;^UTILITY(U,$J,358.3,14188,2)
 ;;=^5133585
 ;;^UTILITY(U,$J,358.3,14189,0)
 ;;=I69.932^^83^822^32
 ;;^UTILITY(U,$J,358.3,14189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14189,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Upper Dominant Side
 ;;^UTILITY(U,$J,358.3,14189,1,4,0)
 ;;=4^I69.932
 ;;^UTILITY(U,$J,358.3,14189,2)
 ;;=^5133580
 ;;^UTILITY(U,$J,358.3,14190,0)
 ;;=I69.934^^83^822^33
 ;;^UTILITY(U,$J,358.3,14190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14190,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Upper Nondominant Side
 ;;^UTILITY(U,$J,358.3,14190,1,4,0)
 ;;=4^I69.934
 ;;^UTILITY(U,$J,358.3,14190,2)
 ;;=^5133583
 ;;^UTILITY(U,$J,358.3,14191,0)
 ;;=I69.941^^83^822^34
 ;;^UTILITY(U,$J,358.3,14191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14191,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Lower Dominant Side
 ;;^UTILITY(U,$J,358.3,14191,1,4,0)
 ;;=4^I69.941
 ;;^UTILITY(U,$J,358.3,14191,2)
 ;;=^5133581
 ;;^UTILITY(U,$J,358.3,14192,0)
 ;;=I69.943^^83^822^35
 ;;^UTILITY(U,$J,358.3,14192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14192,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Nondominant Side
 ;;^UTILITY(U,$J,358.3,14192,1,4,0)
 ;;=4^I69.943
 ;;^UTILITY(U,$J,358.3,14192,2)
 ;;=^5133584
 ;;^UTILITY(U,$J,358.3,14193,0)
 ;;=I69.931^^83^822^36
 ;;^UTILITY(U,$J,358.3,14193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14193,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Upper Dominant Side
 ;;^UTILITY(U,$J,358.3,14193,1,4,0)
 ;;=4^I69.931
 ;;^UTILITY(U,$J,358.3,14193,2)
 ;;=^5007558
 ;;^UTILITY(U,$J,358.3,14194,0)
 ;;=I69.933^^83^822^37
 ;;^UTILITY(U,$J,358.3,14194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14194,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Upper Nondominant Side
 ;;^UTILITY(U,$J,358.3,14194,1,4,0)
 ;;=4^I69.933
 ;;^UTILITY(U,$J,358.3,14194,2)
 ;;=^5007559
 ;;^UTILITY(U,$J,358.3,14195,0)
 ;;=I69.998^^83^822^44
 ;;^UTILITY(U,$J,358.3,14195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14195,1,3,0)
 ;;=3^Cerebrovascular Disease,Sequelae,Unspec
 ;;^UTILITY(U,$J,358.3,14195,1,4,0)
 ;;=4^I69.998
 ;;^UTILITY(U,$J,358.3,14195,2)
 ;;=^5007572
 ;;^UTILITY(U,$J,358.3,14196,0)
 ;;=I69.928^^83^822^45
 ;;^UTILITY(U,$J,358.3,14196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14196,1,3,0)
 ;;=3^Cerebrovascular Disease,Speech/Language Deficits,Unspec
 ;;^UTILITY(U,$J,358.3,14196,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,14196,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,14197,0)
 ;;=I69.965^^83^822^39
 ;;^UTILITY(U,$J,358.3,14197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14197,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,14197,1,4,0)
 ;;=4^I69.965
 ;;^UTILITY(U,$J,358.3,14197,2)
 ;;=^5007566
 ;;^UTILITY(U,$J,358.3,14198,0)
 ;;=I69.962^^83^822^40
 ;;^UTILITY(U,$J,358.3,14198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14198,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Dominant Side
 ;;^UTILITY(U,$J,358.3,14198,1,4,0)
 ;;=4^I69.962
 ;;^UTILITY(U,$J,358.3,14198,2)
 ;;=^5133588
